Get my own profile
Public access
View all8 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Christian TyrchanSenior Director Computational Chemistry, BioPharmaceuticals R&D, Early R&I, AstraZenecaVerified email at astrazeneca.com
- Jan KihlbergProfessor i Organisk kemiVerified email at kemi.uu.se
- Matthew W D PerryMedicinal Chemistry, RIA iMed, AstraZenecaVerified email at astrazeneca.com
- Dr. Björn OverRhein-Chemotechnik GmbHVerified email at rhein-chemotechnik.com
- Per ArturssonUppsala universityVerified email at farmaci.uu.se
- Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of GothenburgVerified email at gu.se
- Bradley DoakMonash UniversityVerified email at monash.edu
- Simon B. DuckettUniversity of YorkVerified email at york.ac.uk
- Igor ShamovskyMedicinal Chemistry, RIA iMed, AstraZenecaVerified email at astrazeneca.com
- Martin E CooperMedicinal Chemistry, RIA iMed, AstraZenecaVerified email at astrazeneca.com
- charles elmoreastrazenecaVerified email at astrazeneca.com
- Peter SjöDrugs for Neglected Disease initiativeVerified email at dndi.org
- Lena RipaRIA iMed, AstraZenecaVerified email at astrazeneca.com
- Tomas LeekRIA iMed, AstraZenecaVerified email at astrazeneca.com
- Jörgen SamuelssonKarlstad UniversityVerified email at kau.se
- Torgny FornstedtKarlstad UniversitetVerified email at kau.se
- Frank NarjesSenior Principal Scientist, Medicinal Chemistry, AstraZeneca ABVerified email at astrazeneca.com
- Bruce DembofskyAvantor IncVerified email at avantorsciences.com
- Hanna LeekEarly Chemical Development, Pharmaceutical Sciences, AstraZenecaVerified email at astrazeneca.com
- Linda ThunbergMedicinal Chemistry, RIA iMed, AstraZenecaVerified email at astrazeneca.com